BioNTech SE (BNTX) Non Operating Income (2020 - 2025)
BioNTech SE (BNTX) reported Non Operating Income of $111.4 million for Q2 2025, down 35.52% on a YoY basis from $172.7 million in Q2 2024, and up 19.38% sequentially from $93.3 million in Q1 2025.
BioNTech SE (BNTX) Non Operating Income (2020 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 6 years of Non Operating Income data on file, last reported at $111.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 111.38 Mn |
| Mar 31, 2025 | 93.30 Mn |
| Sep 30, 2024 | 162.76 Mn |
| Jun 30, 2024 | 172.73 Mn |
| Mar 31, 2024 | 190.55 Mn |
| Sep 30, 2023 | 167.97 Mn |
| Jun 30, 2023 | 164.54 Mn |
| Mar 31, 2023 | 57.21 Mn |
| Sep 30, 2022 | 113.63 Mn |
| Jun 30, 2022 | 304.43 Mn |
| Mar 31, 2022 | 320.20 Mn |
| Sep 30, 2021 | 66.16 Mn |
| Jun 30, 2021 | 211.47 Mn |
| Mar 31, 2021 | 24.00 Mn |
| Sep 30, 2020 | 24.65 Mn |